Osborne Clarke LLP

Recognised for its strength in IP litigation, pharma and biotech clients rely on Osborne Clarke LLP for support in high-value UK and UPC litigation, SPCs and data and marketing exclusivity disputes. The practice is also active in ventures – handling spin-outs, technology transfer, commercialisation and investment transactions – and public and private healthcare matters, recently advising on NHS procurement. Practice head Will James is an experienced patent litigator, recently active in biotech disputes before the UPC. The team was further strengthened by the arrival of transactional lawyer Mathilda Davidson from Gowling WLG and competition litigator Aqeel Kadri from Hausfeld & Co LLP in January 2025, as well as IP litigator John Linneker, who joined from Fieldfisher in November 2024.